BEAM Beam Therapeutics Inc.

Fundamentals / CIK 0001745999 / USD

Beam Therapeutics Inc. reported $146.6M in revenue and a net loss of $108.4M for the trailing twelve months ended September 30, 2026 (down 96.8% year over year), with a -267.7% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open BEAM in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

7 fiscal years (2019 to 2025), reported in USD.

$412.1M$206.0M$0-$384.4MFY 2019 Revenue: $18KFY 2019 Net Income: -$78.33M2019FY 2020 Revenue: $24KFY 2020 Net Income: -$194.6M2020FY 2021 Revenue: $51.84MFY 2021 Net Income: -$370.6M2021FY 2022 Revenue: $60.92MFY 2022 Net Income: -$289.1M2022FY 2023 Revenue: $377.7MFY 2023 Net Income: -$132.5M2023FY 2024 Revenue: $63.52MFY 2024 Net Income: -$376.7M2024FY 2025 Revenue: $139.7MFY 2025 Net Income: -$79.99M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $139.7M $63.52M $377.7M $60.92M $51.84M $24K $18K
Research & Development $409.6M $367.6M $437.4M $311.6M $387.1M $103.2M $54.62M
Total Operating Expenses $523.4M $479.1M $554.2M $399.4M $444.3M $132.8M $75.17M
Operating Income -$383.7M -$415.6M -$176.5M -$338.5M -$392.5M -$132.8M -$75.15M
EBITDA -$361.4M -$393.6M -$156.5M -$324.3M -$385.0M -$128.0M -$71.65M
Income Before Tax -$79.99M -$376.7M -$131.2M -$260.2M -$370.6M -$194.6M --
Income Tax Expense $0 $39K $1.37M $3.41M $0 $0 $0
Net Income -$79.99M -$376.7M -$132.5M -$289.1M -$370.6M -$194.6M -$78.33M
Basic EPS -$0.81 -$4.58 -$1.72 -$4.13 -$5.77 -$4.19 -$14.05
Diluted EPS -$0.81 -$4.58 -$1.72 -$4.13 -$5.77 -$4.19 -$14.05
Basic Shares Outstanding 98.9M 82.3M 77.2M 70.0M 64.2M 46.7M 6.5M
Diluted Shares Outstanding 98.9M 82.3M 77.2M 70.0M 64.2M 46.7M 6.5M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $307K $490K $31.74M $114.1M $9.70M $8.47M $7.47M $30.07M
Research & Development $110.1M $95.10M $104.5M $99.28M $109.8M $101.8M $98.82M $101.4M
Total Operating Expenses $141.6M $127.0M $139.0M $131.6M $136.5M $128.6M $126.8M $130.1M
Operating Income -$141.3M -$126.6M -$107.2M -$17.45M -$126.8M -$120.2M -$119.3M -$100.0M
EBITDA -$135.9M -$121.1M -$101.6M -$11.78M -$121.3M -$114.6M -$113.8M -$94.59M
Income Before Tax -- -- -- -- -$112.7M -$102.3M -- --
Income Tax Expense $0 $0 $0 $0 $0 $0 $0 $0
Net Income -$134.4M -$122.7M -$94.32M $243.0M -$112.6M -$102.1M -$108.3M -$90.35M
Basic EPS -$1.28 -$1.18 -$0.91 -- -$1.10 -$1.00 -$1.23 --
Diluted EPS -$1.28 -$1.18 -$0.91 -- -$1.10 -$1.00 -$1.23 --
Basic Shares Outstanding 104.7M 104.3M 103.3M -- 102.6M 102.0M 88.0M --
Diluted Shares Outstanding 104.7M 104.3M 103.3M -- 102.6M 102.0M 88.0M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $294.9M $282.0M $435.9M $232.8M $560.0M $162.2M $37.22M
Short-Term Investments $950.3M $568.8M $754.0M $845.4M -- $137.5M --
Cash & Short-Term Investments $1.20B $850.7M $1.20B $1.10B $965.6M $299.7M $37.22M
Total Current Assets $1.27B $878.1M $1.21B $1.09B $1.27B $308.3M $94.54M
Property, Plant & Equipment, Net $104.5M $111.4M $125.0M $115.6M $84.26M $38.51M $24.29M
Long-Term Investments -- -- -- -- -- $2.58M --
Other Non-Current Assets $634K $1.25M $2.15M $1.93M $1.72M $3.14M $4.98M
Total Non-Current Assets $212.5M $225.7M $248.7M $248.8M $201.4M $143.4M $61.55M
Total Assets $1.48B $1.10B $1.46B $1.34B $1.47B $451.7M $156.1M
Accounts Payable $10.23M $3.87M $1.62M $9.03M $7.47M $6.31M $7.85M
Deferred Revenue (Current) $6.66M $108.9M $68.71M $136.0M $86.27M $24K --
Total Current Liabilities $96.94M $182.1M $205.6M $223.6M $213.4M $102.3M $29.14M
Deferred Revenue (Non-Current) $0 $33.22M $109.9M $202.2M $262.3M $394K --
Other Non-Current Liabilities $173K $504K $298K $1.38M $2.79M $2.08M $418K
Total Non-Current Liabilities $145.9M $188.2M $272.8M $384.6M $434.3M $103.8M $26.02M
Total Liabilities $242.8M $370.3M $478.4M $608.2M $647.7M $206.1M $55.15M
Total Debt (incl. Leases) $154.1M $161.4M $172.7M $182.0M $147.6M $107.6M $31.24M
Common Stock $1.02M $836K $816K $712K $684K $573K $73K
Retained Earnings -$1.64B -$1.57B -$1.19B -$1.06B -$768.3M -$397.6M -$203.0M
Accumulated Other Comp. Income $1.11M $679K $604K -$2.43M -$50K -$9.0K $16K
Total Stockholders' Equity $1.24B $733.5M $981.3M $733.5M $826.7M $245.6M -$201.1M
Total Equity $1.24B $733.5M $981.3M $733.5M $826.7M $245.6M -$201.1M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $213.3M $219.8M $288.3M $294.9M $268.0M $282.1M $527.9M $282.0M
Short-Term Investments $830.6M $933.1M $923.4M $950.3M $807.0M $868.2M $692.0M $568.8M
Cash & Short-Term Investments $1.00B $1.20B $1.20B $1.20B $1.10B $1.20B $1.20B $850.7M
Total Current Assets $1.07B $1.18B $1.27B $1.27B $1.10B $1.18B $1.25B $878.1M
Property, Plant & Equipment, Net $94.04M $97.61M $101.2M $104.5M $108.3M $108.8M $109.6M $111.4M
Other Non-Current Assets $7.96M $7.86M $7.76M $634K $593K $668K $911K $1.25M
Total Non-Current Assets $201.7M $207.8M $213.8M $212.5M $212.5M $215.7M $219.3M $225.7M
Total Assets $1.27B $1.39B $1.48B $1.48B $1.31B $1.39B $1.47B $1.10B
Accounts Payable $20.14M $13.10M $12.29M $10.23M $9.54M $10.56M $7.70M $3.87M
Deferred Revenue (Current) $0 $0 $304K $6.66M $110.3M $105.8M $85.20M $108.9M
Total Current Liabilities $82.08M $80.88M $74.56M $96.94M $182.6M $174.1M $141.5M $182.1M
Long-Term Debt $100.4M $100.3M $100.2M -- -- -- -- --
Deferred Revenue (Non-Current) -- -- -- $0 $10.16M $20.32M $49.40M $33.22M
Other Non-Current Liabilities $368K $293K $305K $173K $266K $357K $414K $504K
Total Non-Current Liabilities $234.3M $238.0M $241.8M $145.9M $162.5M $170.2M $202.2M $188.2M
Total Liabilities $316.4M $318.9M $316.4M $242.8M $345.1M $344.3M $343.8M $370.3M
Total Debt (incl. Leases) $243.9M $247.4M $250.8M $154.1M $151.4M $154.8M $158.1M $161.4M
Common Stock $1.03M $1.03M $1.03M $1.02M $1.01M $1.01M $1.01M $836K
Retained Earnings -$1.99B -$1.86B -$1.74B -$1.64B -$1.89B -$1.78B -$1.68B -$1.57B
Accumulated Other Comp. Income -$3.43M -$2.19M -$1.07M $1.11M $790K $10K $160K $679K
Total Stockholders' Equity $952.7M $1.07B $1.16B $1.24B $972.7M $1.05B $1.13B $733.5M
Total Equity $952.7M $1.07B $1.16B $1.24B $972.7M $1.05B $1.13B $733.5M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$79.99M -$376.7M -$132.5M -$289.1M -$370.6M -$194.6M -$78.33M
Depreciation & Amortization $22.29M $21.93M $20.01M $14.15M $7.45M $4.74M $3.50M
Stock-Based Compensation $94.24M $120.7M $98.65M $84.32M $43.57M $15.38M $7.03M
Change in Payables $6.04M $1.81M -$7.58M $2.37M $818K $60K $4.09M
Operating Cash Flow -$345.1M -$347.2M -$149.2M $22.53M -$66.27M -$95.74M -$72.00M
Capital Expenditure -$14.95M -$8.95M -$33.73M -$48.95M -$46.81M -$16.36M -$12.52M
Free Cash Flow -$360.0M -$356.2M -$182.9M -$26.42M -$113.1M -$112.1M -$84.52M
Acquisitions, Net -$78K $0 $0 -- -- -- --
Purchases of Investments -$1.21B -$486.4M -$984.3M -$1.62B -$777.2M -$281.6M -$129.8M
Sales & Maturities of Investments $848.2M $680.4M $1.09B -- -- -- --
Investing Cash Flow -$121.4M $185.0M $71.84M -$461.3M -$294.1M -$100.1M -$66.66M
Common Stock Issued -- -- $236.6M $108.3M $757.4M -- --
Financing Cash Flow $478.0M $7.74M $276.4M $111.6M $756.1M $322.3M $41.28M
Net Change in Cash $11.51M -$154.5M $199.1M -$327.2M $395.7M $126.5M -$97.38M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$134.4M -$122.7M -$94.32M $243.0M -$112.6M -$102.1M -$108.3M -$90.35M
Depreciation & Amortization $5.45M $5.41M $5.61M $5.67M $5.56M $5.54M $5.53M $5.44M
Stock-Based Compensation $18.55M $19.28M $19.04M $20.45M $22.75M $24.37M $26.68M $30.22M
Change in Payables $2.46M $1.21M $2.22M $1.19M -$1.59M $2.64M $3.79M -$550K
Operating Cash Flow -$110.7M -$66.10M -$128.5M -$83.29M -$81.48M -$76.45M -$103.9M -$76.36M
Capital Expenditure -$1.21M -$2.41M -$2.23M -$3.73M -$5.01M -$3.14M -$3.06M -$2.97M
Free Cash Flow -$112.0M -$68.51M -$130.7M -$87.02M -$86.49M -$79.59M -$106.9M -$79.33M
Purchases of Investments -$109.6M -$180.9M -$153.8M -$361.0M -$175.6M -$333.9M -$339.2M $0
Investing Cash Flow $101.9M -$9.88M $25.27M $108.4M $65.66M -$170.4M -$125.1M $126.3M
Financing Cash Flow $2.33M $7.52M $96.61M $1.89M $1.68M $1.11M $473.4M $3.44M
Net Change in Cash -$6.56M -$68.45M -$6.64M $27.00M -$14.15M -$245.8M $244.4M $53.36M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -274.6% -654.3% -46.7% -555.6% -757.0% -553166.7% -417522.2%
Net Profit Margin -57.2% -593.1% -35.1% -474.5% -714.9% -810800.0% -435144.4%
Return on Equity (ROE) -6.5% -51.4% -13.5% -39.4% -44.8% -79.2% --
Return on Assets (ROA) -5.4% -34.1% -9.1% -21.5% -25.1% -43.1% -50.2%
Current Ratio 13.09x 4.82x 5.89x 4.89x 5.96x 3.01x 3.24x
Quick Ratio 12.38x 4.67x 5.84x 4.92x 4.52x 2.93x 1.28x
Debt to Equity 0.12x 0.22x 0.18x 0.25x 0.18x 0.44x --
Revenue Growth (YoY) +120.0% -83.2% +520.0% +17.5% +215916.7% +33.3% --
Operating Cash Flow Growth (YoY) -- -- -762.3% -- -- -- --
5Y Revenue / Share Growth +275021.0% +27678.2% -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -267.7% -242.3% -226.6% -274.6% -837.1% -739.9% -677.5% -654.3%
Net Profit Margin -73.9% -55.4% -40.2% -57.2% -742.2% -659.5% -607.8% -593.1%
Return on Equity (ROE) -11.4% -8.1% -5.7% -6.5% -42.5% -37.7% -34.2% -51.4%
Return on Assets (ROA) -8.5% -6.2% -4.5% -5.4% -31.5% -28.6% -26.3% -34.1%
Current Ratio 13.00x 14.57x 16.99x 13.09x 6.02x 6.75x 8.81x 4.82x
Quick Ratio 12.18x 14.84x 16.09x 12.38x 6.03x 6.89x 8.48x 4.67x
Debt to Equity 0.26x 0.23x 0.22x 0.12x 0.16x 0.15x 0.14x 0.22x
Revenue Growth (YoY) -96.8% -94.2% +324.9% +279.5% -32.0% -28.1% +0.8% -90.5%
Operating Income Growth (YoY) -- -- -- -- -- -- -- -175.3%
Net Income Growth (YoY) -- -- -- -- -- -- -- -163.3%
Operating Cash Flow Growth (YoY) -- -- -- -- -- -- -- -156.5%
Free Cash Flow Growth (YoY) -- -- -- -- -- -- -- -160.3%
Source: SEC EDGAR CompanyFacts (CIK 0001745999) · from March 31, 2019 Data through September 30, 2026 · synced Nov 20, 2026, 05:21 UTC · Open in terminal